GrantExec, a Euna Solutions® company

Grants for City or township governments - Health

Explore 3,574 grant opportunities

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
$250,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 15, 2024

Date Added

Jun 5, 2025

This funding opportunity supports researchers and institutions in validating high-quality biomarkers and assays for cancer detection, diagnosis, and treatment monitoring, facilitating their integration into clinical studies.

Education
State governments
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 3, 2025

Date Added

Aug 9, 2023

This funding opportunity supports experienced laboratory scientists engaged in cancer research within NCI-funded projects, providing salary support and travel funds to enhance their contributions without requiring them to become independent investigators.

Education
State governments
Rural Mental Health Initiative Grant Program
$250,000
Texas Health and Human Services Commission
State

Application Deadline

Jul 3, 2024

Date Added

Jun 12, 2024

The Texas Health and Human Services Commission (HHSC), the System Agency, is accepting Applications for the Rural Mental Health Initiative Grant Program (RIGP) as directed by Senate Bill 1677, 88th Legislature, Regular Session, 2023. Through the Rural Mental Health Initiative Grant Program, HHSC will award grants to Rural serving Local Mental Health Authorities (LMHAs), Local Behavioral Health Authorities (LBHAs), nonprofit organizations, or governmental entities to be matched in accordance with the specifications outlined in Section 5.4., to address the mental health needs of individuals with mental illness or serious emotional disturbance residing in Rural Texas in accordance with the specifications contained in this Request for Application.

Law Justice and Legal Services
Nonprofits
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required)
$100,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

May 7, 2024

Date Added

May 12, 2020

The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH program that provides support and "protected time" to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research.

Education
State governments
Exploring Proteogenomic Approaches to Unravel the Mechanisms of Mis-Folded Protein Accumulation in Tauopathies (R01 Clinical Trial Not Allowed)
$500,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jun 10, 2024

Date Added

Mar 14, 2024

Notice of Funding Opportunity Description Background The accumulation of misprocessed and aberrant proteins is a defining characteristic of various neurodegenerative conditions, such as AD and frontotemporal lobar degeneration (FTLD). These atypical proteins may arise from various factors, such as somatic mutations, environmental changes, genomic instability, irregular RNA processing, and proteolytic cleavages, as well as incorrect folding and post-translational modifications. For instance, many recent proteome and transcriptome profiling of AD brains reveals RNA splicing dysfunction and abnormal accumulation of U1 small nuclear ribonucleoprotein (snRNP) and transactive response DNA-binding protein 43 (TDP-43). In AD, U1-70K and its N-terminal 40-KDa fragment (N40K) is one of the most abundant proteins in the insoluble fraction of cell lysates. TDP-43 is an RNA-binding protein. In AD, TDP-43 pathology is observed in approximately 25-50% of cases, particularly in cases with co-morbidities such as Lewy body dementia or hippocampal sclerosis. However, the relationship between U1snRNP/TDP-43 and AD pathology is complex and not fully understood. The disruption of RNA processing is thought to be one possible mechanism to cause the accumulation of misprocessed proteins, which can lead to altered expression of genes involved in AD pathology, including amyloid precursor protein (APP), tau, and synaptic proteins. Understanding the mechanisms underlying the dysregulation of misprocessed proteins in neurodegenerative diseases will be important for developing effective therapies. Approaches that target the production or aggregation of misprocessed proteins, or that promote their clearance or degradation, may be effective in preventing or slowing disease progression. Purpose This NOFO invites innovative research proposals to explore the accumulation of misprocessed proteins in Tauopathies within specific brain regions and cell types. This NOFO encourages collaborative efforts to create advanced single-cell or single-cell type proteogenomic platforms. These platforms aim to shed light on dynamic changes in protein-misfolding responses in neuronal proteomes and their potential biological consequences during aging and the development of AD/ADRD. Research Objectives This NOFO aims to provide a proof-of-principal for a novel strategy to identify misprocessed and aberrant proteins in Tau diseases using the proteogenomic approach. Proteogenomics is an integrated approach that combines proteomics and genomics data. In proteogenomics, genomic and transcriptomic experiments are more closely integrated to identify potential protein coding and non-coding regions in the genome. These regions are then validated using mass spectrometry-based proteomics. Proteogenomics has emerged as a powerful tool for investigating the role of protein homeostasis in AD pathogenesis, especially in the context of mis-translated and mis-repaired proteins. However, relying solely on misprocessed protein levels to draw conclusions about biological processes is unlikely to be reliable. Therefore, an intermediate layer of functional validation is essential to transform proteogeomic data into meaningful biological information. As a result, the objective of this NOFO is not only to confirm changes in protein abundance using other methods, but also to assess the biological effects of those changes in some model systems, especially in the area of tauopathies, to ensure high interlaboratory reproducibility. Using the proteogenomics approach, this NOFO aims to accomplish the following: Create a comprehensive database of misprocessed and aberrant proteins in selected mouse models of human Tau diseases. Cross-validate the presence of misprocessed and aberrant proteins in human AD/ADRD brains. Identify new molecular pathways and novel misprocessed protein-protein interaction networks that are not currently in most datasets. Define novel mechanisms through which misprocessed and aberrant proteins influence the onset and progression of neurodegeneration in tauopathies. Identify disease specific therapeutic targets in neurodegenerative diseases. It is expected that applications responding to this initiative will use the latest cell-type-specific labeling and proteogenomic techniques with suitable model systems to understand the etiology of tauopathies in aging and AD.

Health
State governments
Promoting Innovative Research in Treponema pallidum Pathogenesis (R21 Clinical Trial Not Allowed)
$200,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 4, 2024

Date Added

Aug 5, 2024

This funding opportunity supports researchers exploring the mechanisms of Treponema pallidum, the bacteria responsible for syphilis, to address the rising rates of sexually transmitted infections and improve understanding of its pathogenesis.

Health
State governments
Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings (R34 Clinical Trial Required)
$1,500,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 23, 2025

Date Added

Mar 19, 2024

This grant provides funding for research projects that test strategies to reduce suicide risk by promoting safe storage of lethal means, such as firearms, in healthcare and community settings.

Health
State governments
City of Newark Love Your Block Grant Program
$5,000
City of Newark
Local

Application Deadline

Aug 15, 2024

Date Added

Jul 15, 2024

The City of Newark's Love Your Block (LYB) Mini-Grants Program is a community-driven initiative aimed at fostering neighborhood beautification and community building through collaborative projects between residents, city departments, and local organizations. This program aligns with a broader mission of empowering residents to actively shape their communities, promoting a sense of ownership and pride, and ultimately creating cleaner, greener, and healthier neighborhoods. The underlying theory of change suggests that by providing accessible funding and technical support, resident-led initiatives will lead to tangible improvements and stronger community ties. The primary beneficiaries of this program are individuals, resident groups, and community organizations within the City of Newark who are passionate about enhancing their local environments. The program's impact goals are centered on reducing litter, improving waste management, revitalizing underutilized properties, and enhancing green spaces. By engaging residents directly in these efforts, the program aims to cultivate a more vibrant and engaged citizenry, leading to sustainable community improvements and a better quality of life for all residents. The program's priorities and focuses are clearly delineated into three grant categories: Community clean-ups, Minor exterior home repairs & curb appeal, and Enhancing Green Spaces and Activating Vacant Lots. These categories reflect the city's strategic priorities in addressing key challenges such as litter, property blight, and underutilized public spaces. The emphasis on these areas is designed to produce visible and impactful results that resonate with residents' everyday experiences and contribute to the overall aesthetic and environmental health of the city. Expected outcomes include a noticeable reduction in litter and an improvement in recycling efforts, the repurposing of dormant or underutilized properties, and the enhancement of community advantages around parks and open areas. Measurable results will likely be observed through the number of successful clean-up events, the completion of home repair and curb appeal projects, and the transformation of vacant lots into valuable community assets. The program's reimbursement-based funding of up to $5,000 per project, coupled with targeted technical assistance, is designed to ensure that these initiatives are achievable and produce meaningful, lasting change within the designated project period of September 2024 to November 15, 2024.

Diversity Equity and Inclusion
City or township governments
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
$750,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 21, 2024

Date Added

Mar 11, 2021

The "Innovation Grants to Nurture Initial Translational Efforts (IGNITE)" program supports the development of in vitro and ex vivo assays to identify and characterize new therapeutic agents for neurological and neuromuscular disorders, with a focus on creating robust screening methods for promising neurotherapeutics.

Health
State governments
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
$275,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 5, 2024

Date Added

Apr 4, 2024

This funding opportunity supports exploratory preclinical studies to evaluate the effectiveness of therapeutic agents for rare diseases affecting fewer than 200,000 people in the U.S., aiming to advance these treatments toward clinical trials.

Health
State governments
NIDCD's Mentoring Networks to Enhance Clinician-Scientists' Participation in Research (R25 Clinical Trial Not Allowed)
$250,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 1, 2024

Date Added

Jan 29, 2024

The "NIDCD's Mentoring Networks to Enhance Clinician-Scientists' Participation in Research" grant aims to support educational and mentoring activities that encourage individuals, especially those from diverse backgrounds, to pursue research careers in biomedical, behavioral, and clinical sciences, with a particular focus on improving the recruitment, preparation, and retention of clinician investigators.

Health
State governments
NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional)
$500,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jun 20, 2025

Date Added

Jul 26, 2022

This grant provides funding to early-career researchers in mental health to support innovative projects that advance the understanding and treatment of mental illnesses.

Health
State governments
Capacity Building Assistance (CBA) for HIV Prevention Programs to End the HIV Epidemic in the United States
$127,500,000
HHS-CDC-NCHHSTP (Centers for Disease Control - NCHHSTP)
Federal

Application Deadline

May 20, 2024

Date Added

Mar 22, 2024

This program will constitute a national CBA Provider Network (CPN) to deliver CBA services to an interdisciplinary HIV prevention workforce (e.g., professional, technical, clinical, and managerial staff) within CDC-funded state and local health departments and CBOs. In the United States, an estimated 1.2 million people are living with HIV. In recent years, the number of people with HIV (PWH) has increased while deaths have declined. Of PWH, about 87% were aware of their HIV status. In 2021, among people with diagnosed HIV, an estimated 75% received HIV medical care and 66% were virally suppressed. Promising progress has been made in HIV prevention as the estimated annual new HIV infections were 12% lower in 2021 (32,100 infections) compared to 2017 (36,500 infections). This decline was largely driven by a substantial decrease (34%) in new infections among 13- to 24-year-olds, mostly among gay and bisexual males. However, HIV prevention efforts must go further, and progress must be faster, for gains to equitably reach all populations and end the HIV epidemic. The National HIV/AIDS Strategy (NHAS) for the United States focuses on four goals: preventing new HIV infections, improving HIV-related health outcomes of people with HIV, reducing HIV-related disparities and health inequities, and achieving integrated, coordinated efforts that address the HIV epidemic among all partners. Successful HIV programs must recognize the syndemics that affect the people and places disproportionately affected by HIV. A syndemic is population-level clustering of social and health problems. In the context of HIV, a syndemic is when HIV clusters with one or more other diseases or health conditions within a specific population, driven by the contextual, structural and social factors that increase the adverse effects on the health of people and communities. Syndemics may include HIV, STIs, TB, viral hepatitis, overdose, and substance use, and other existing and emerging conditions or factors that may be related to or impact HIV. The Ending the HIV Epidemic in the US (EHE) initiative focuses on scaling up four sciencebased strategies in communities most affected by HIV across the country. The strategies are to diagnose all people with HIV as early as possible; treat people with HIV rapidly and effectively to result in sustained viral suppression; prevent new HIV transmissions by using proven interventions, including condom distribution, pre-exposure prophylaxis (PrEP), postexposure prophylaxis (PEP), and syringe services programs (SSP); and respond quickly to potential HIV outbreaks to get vital prevention and treatment services to people who need them. Toward achieving national HIV prevention goals, the Centers for Disease Control and Prevention (CDC) funds state and local health departments and community-based organizations (CBOs) to plan, integrate, implement, evaluate, and sustain HIV prevention and surveillance programs, prioritizing people disproportionately affected by HIV including gay, bisexual, and other men who have sex with men, in particular Black, Latino, and American Indian/Alaska Native men, Black women, transgender women, youth aged 13-24, and people who inject drugs. Racism, HIV stigma, discrimination, homophobia, poverty, and barriers to health care continue to drive disparities in HIV prevention. Building individual competencies and technical expertise among staff, strengthening organizational capacities, and enabling supportive structural environments are critical strategies Page 5 of 81 in addressing operational challenges for more effective HIV prevention and surveillance programs. Reflecting CDC’s continued investment in improving the performance of the nation’s HIV workforce, this NOFO will support the provision of capacity building assistance (CBA) services, including training and technical assistance (TA).

Health
City or township governments
Children, Adolescents Families in the HIV Epidemic in the North West Province
$20,000,000
USAID-SAF (South Africa USAID-Pretoria)
Federal
Rolling

Application Deadline

Not specified

Date Added

Mar 24, 2023

The goal of the Activity is to improve the health, well-being, and protection of children and adolescents (and their families) living with, affected by, and vulnerable to HIV through high-impact service delivery and social service system strengthening to sustain an effective response for children, adolescents, and their families through locally led solutions in North West Province. The United States Agency for International Development (USAID) is seeking applications for acooperative agreement from qualified entities to implement the Children, Adolescents, andFamilies in the HIV Epidemic in North West Province Activity. Subject to funding availabilityand at the discretion of the Agency, USAID intends to provide up to $20 million in total USAIDfunding over a five (5) year period. Eligibility for this award is restricted to local entities (seeSection C.1 of this notice of funding opportunity (NOFO) for eligibility requirements of localentities). USAID encourages applications from potential new local partners. The Activity will beimplemented in the North West Province of South Africa.

Health
County governments
Mechanisms of Cognitive Fluctuations in ADRD Populations (R01 - Clinical Trial Optional)
$825,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jun 24, 2024

Date Added

Mar 19, 2024

"Fluctuating cognition can occur in many types of dementia and is a core clinical feature of Dementia with Lewy Bodies. Cognitive fluctuations can last from seconds to days, are unpredictable (e.g., do not just occur in the evenings, as with sun-downing), and are associated with poor daily functioning for the patient. A number of small studies have suggested that cognitive fluctuations in subjects with dementia may be related to epileptiform discharges and impaired oscillatory activity on EEG, but it is not clear that these are the only factors involved in patient populations that often experience dysautonomia, orthostasis, and sleep disturbances. The etiology of cognitive fluctuations may be multi-factorial and may vary in different dementia populations. Understanding the physiology related to cognitive fluctuations is a critical next step to the development of treatment approaches and improving quality of life for these patients. This initiate would encourage research that will better characterize the physiology responsible for cognitive fluctuations in ADRD populations. Given their variable appearance and time course, it is anticipated that wearable digital devices will be important for capturing fluctuations in a timely fashion, and applicants should consider incorporating those device(s) capable of acquiring the relevant data to support the hypothesized mechanism(s). Applicants may focus on assessing multiple mechanisms in a specific ADRD population, or may chose to compare mechanisms across multiple types of ADRDs. "

Health
State governments
Covering Equitable Community Development Journalism Fellowship
Contact for amount
National Press Foundation
Private

Application Deadline

Sep 2, 2024

Date Added

Aug 5, 2024

The National Press Foundation is offering the Covering Equitable Community Development Journalism Fellowship, an expenses-paid program designed to enhance journalists' ability to report on equitable community development. This initiative aligns with the foundation's mission to support and educate journalists, specifically by equipping them to investigate the intersection of policy, public and private financing, and calls for equitable housing, parks, and other community assets. The program aims to address the critical need for comprehensive and nuanced reporting on how resources are allocated and what initiatives receive support within various regions. The target beneficiaries of this fellowship are U.S.-based journalists working across print, TV, radio, or online media, with a particular encouragement for those who cover race and metro beats. The program emphasizes diversity and welcomes applicants from across the nation. The impact goal is to empower these journalists to better understand and report on pervasive racial gaps and the policies and investments in their communities related to health, wealth, and overall community well-being. By providing specialized training, the fellowship seeks to foster a more informed public discourse on community development issues. The fellowship's priorities and focuses include an immersive exploration into community development issues, especially in the context of small and mid-sized cities. The program will delve into how financing and investing institutions—such as community development financial institutions (CDFIs), philanthropic impact investors, private banks, and other investors—prioritize projects. It will also examine how policymakers and public officials can actively involve residents in decision-making and ensure accountability for anti-racist practices in the community development sector. Other key topics include identifying conditions that lead to healthier, more equitable communities with access to essential resources like affordable housing, education, and healthcare, as well as addressing environmental justice as a community development issue. The expected outcomes and measurable results of this fellowship include equipping journalists with the knowledge and context to add breadth to their coverage of community development. By bringing together experts from health equity, nonprofit, policy, financing, and community organizing sectors, the program anticipates that fellows will gain a deeper understanding of complex issues. While specific measurable results are not explicitly stated as quantitative metrics, the qualitative outcome is a more capable and informed journalistic body that can investigate and report on community development effectively, potentially leading to increased public awareness and accountability in these areas.

Community Development
City or township governments
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 12, 2025

Date Added

Oct 30, 2023

This funding opportunity supports research on the ethical, legal, and social implications of human genetics and genomics, particularly focusing on diverse perspectives and community engagement.

Education
State governments
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 2, 2024

Date Added

Jan 24, 2024

(Reissue PAR-21-056) The purpose of this Program Announcement (PAR) is to enable analytical validation of strong candidate biomarkers for neurological diseases and conditions. Specifically, the goal of this PAR is to enable the rigorous validation of analytical methods for biomarker measurements, including evaluation of the detection method, its performance characteristics, and the optimal conditions that will generate reproducibility and accuracy consistent with FDA guidelines. This PAR assumes that 1) a candidate biomarker has already been identified, 2) detection method technology has already been developed, and 3) the research and/or clinical need and potential context of use has been identified.

Health
State governments
Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Aug 14, 2025

Date Added

Aug 26, 2024

This grant provides funding for researchers to study how HIV and substance use disorder affect brain cell function, with the goal of uncovering new treatment strategies for individuals facing these combined challenges.

Education
State governments
Small Businesses impacted by Pandemic in Florida
$10,000
City of Port St. Lucie
Local
Rolling

Application Deadline

Not specified

Date Added

Mar 26, 2024

The City of Port St. Lucie, in partnership with the Florida Small Business Development Center at Indian River State College, launched the COVID-19 Small Business Grant Program to financially support businesses affected by the pandemic. This program serves as a reimbursement grant, providing up to $10,000 for business-related expenses such as mortgage, rent, utilities, insurance, reopening costs, safety measures, and payroll during closures. The initiative is funded by FloridaCommerce through its Community Development Block Grant Coronavirus Program, demonstrating a commitment to economic recovery and stability within the community. The program primarily targets small businesses with 0-50 employees that were in operation before March 1, 2020, and have been impacted by the COVID-19 pandemic. A key focus is on businesses located within qualified low-to-moderate-income Census Tracts (QCTs) or owned by individuals whose household income qualifies as low or moderate. This targeting aligns with a broader mission of supporting vulnerable populations and fostering equitable economic recovery within the city. Prioritization is given to applications from small businesses that have not previously received COVID-19 relief funding, ensuring that support reaches those most in need of assistance. The program aims to mitigate the financial strain caused by the pandemic, allowing businesses to cover essential operating costs and implement necessary safety measures. The emphasis on current tax status and registration with the Florida Division of Corporations underscores a commitment to supporting legitimate and compliant businesses. With a total of $390,000 initially available, and approximately $165,000 remaining after 23 approved applicants as of mid-March, the program has already made a significant impact. Expected outcomes include the sustained operation of small businesses, retention of employment, and a more resilient local economy. By providing direct financial relief, the grant contributes to the overall stability and recovery of Port St. Lucie's small business sector, particularly in its low-to-moderate-income areas.

Business and Commerce
City or township governments